ArticleAmerican journal of hematology2012

The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patients.

Michael J Kelly-Sell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.